ResMed Inc. (RSMDF)

OTCMKTS · Delayed Price · Currency is USD
22.00
0.00 (0.00%)
May 8, 2025, 4:00 PM EDT
24.29%
Market Cap 35.93B
Revenue (ttm) 5.02B
Net Income (ttm) 1.31B
Shares Out n/a
EPS (ttm) 8.91
PE Ratio 27.36
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 40
Average Volume 169
Open 23.35
Previous Close 22.00
Day's Range 22.00 - 23.35
52-Week Range 17.70 - 30.00
Beta 0.78
RSI 55.30
Earnings Date Apr 23, 2025

About ResMed

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on de... [Read more]

Sector Healthcare
Founded 1989
Employees 9,980
Stock Exchange OTCMKTS
Ticker Symbol RSMDF
Full Company Profile

Financial Performance

In 2024, ResMed's revenue was $4.69 billion, an increase of 10.95% compared to the previous year's $4.22 billion. Earnings were $1.02 billion, an increase of 13.75%.

Financial Statements

News

Top 15 High-Growth Dividend Stocks To Consider For May 2025

My Top 15 High-Growth Dividend stocks for April 2025 outperformed SPY and VIG, posting a 0.12% gain versus SPY's -0.87% and VIG's -1.53%. Year-to-date, the Top 15 list returned -0.36%, outperforming V...

7 days ago - Seeking Alpha

Resmed Acquires VirtuOx

Acquisition supports Resmed's growth in virtual care, expands access to diagnosis, and enhances the digital experience for patients and providers Acquisition supports Resmed's growth in virtual care, ...

8 days ago - GlobeNewsWire

Billion-dollar medical start-ups say Trump could force a US move

Nanosonics chief executive Michael Kavanagh said the government should step in and help domestic development, a sentiment echoed by ResMed boss Mick Farrell.

12 days ago - The Australian Financial Review

We reaffirmed our tariff relief in 2008 and 2009, we went back again 3 weeks ago, says Resmed CEO

Mick Farrell, Resmed CEO, joins 'Mad Money' host Jim Cramer to talk GLP-1s, the impact of tariffs, quarterly results, and more.

14 days ago - CNBC

ResMed Boasts Double-Digit EPS Growth, Tariff Exemption: Analysts Boost Price Forecast

On Wednesday, ResMed Inc (NYSE: RMD) reported that third-quarter adjusted EPS was $2.37, beating the consensus of $2.36 . Quarterly sales increased 8% year over year to $1.29 billion, which aligns wi...

15 days ago - Benzinga

ResMed Boasts Double-Digit EPS Growth, Tariff Exemption: Analysts Boost Price Forecast

On Wednesday, ResMed Inc RMD reported that third-quarter adjusted EPS was $2.37, beating the consensus of $2.36.

15 days ago - Benzinga

Texas Instruments Posts Better-Than-Expected Results, Joins Community Health Systems, Hasbro, ServiceNow, ResMed And Other Big Stocks Moving Higher On Thursday

U.S. stocks were higher, with the Nasdaq Composite gaining around 300 points on Thursday. Shares of Texas Instruments Incorporated (NASDAQ: TXN) rose sharply during Thursday's session after the compa...

15 days ago - Benzinga

ResMed declares $0.53 dividend

15 days ago - Seeking Alpha

‘Tariff-exempt’ ResMed boosts US manufacturing

Chief executive Mick Farrell says he’s confident the medical device company’s exports from Australia and Singapore will not be subject to Donald Trump’s levies.

16 days ago - The Australian Financial Review

ResMed slightly beats quarterly profit estimates on sleep devices demand

Resmed beat Wall Street estimates for third-quarter profit on Wednesday, driven by demand for its sleep apnea devices used to manage the common sleep disorder.

16 days ago - Reuters

Resmed Inc. Announces Results for the Third Quarter of Fiscal Year 2025

Note: A webcast of Resmed's conference call will be available at 4:30 p.m. ET today at  http://investor.resmed.com

16 days ago - GlobeNewsWire

ASX 200 LIVE: Trump reportedly considering lower China tariffs; miners buoy sharemarket as iron ore climbs

Shares edge higher; Trump may wind down tariff rate on China; Tesla leaps 5pc; ResMed evades trade war blow; iron ore rallies, gold stocks bounce back.

16 days ago - The Australian Financial Review

A Look Ahead: ResMed's Earnings Forecast

ResMed (NYSE: RMD) is gearing up to announce its quarterly earnings on Wednesday, 2025-04-23. Here's a quick overview of what investors should know before the release. Analysts are estimating that Re...

17 days ago - Benzinga

Resmed Names Salli Schwartz as Chief Investor Relations Officer

Former Illumina, MSCI, and Moody's executive brings extensive experience leading engagement with the global investment community Former Illumina, MSCI, and Moody's executive brings extensive experienc...

18 days ago - GlobeNewsWire

Resmed Announces Small, Easy to Use Home Sleep Apnea Test, NightOwl™, Now Available Across the US

SAN DIEGO, April 03, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, today announced its home ...

5 weeks ago - GlobeNewsWire

Resmed to Report Third Quarter Fiscal 2025 Earnings on April 23, 2025

SAN DIEGO, April 02, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of fiscal year 2025 on Wednesday,...

5 weeks ago - GlobeNewsWire

My Top 15 High-Growth Dividend Stocks For April 2025

My Top 15 High-Growth Dividend stocks outperformed SPY and VIG in March, posting a loss of 3.26% compared to SPY's 5.86% and VIG's 4.50%. The April 2025 list offers an average dividend yield of 1.25% ...

5 weeks ago - Seeking Alpha

Lightning Round: Stay away from aluminum, says Jim Cramer

'Mad Money' host Jim Cramer weighs in on stocks including: Resmed, Twilio, NiSource, Reddit, and Google.

7 weeks ago - CNBC

New Global Study Finds: Sleep Apnea Patients Who Use CPAP Live Longer

SAN DIEGO, March 19, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the global leader in health technology focused on sleep, breathing, and care delivered in the home, today announced the publ...

7 weeks ago - GlobeNewsWire

Resmed Unveils Unified Brand to Lead the Global Sleep and Health Technology Revolution

SAN DIEGO, March 11, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, today announced a compreh...

2 months ago - GlobeNewsWire

ResMed Among Top Stocks For Recent And Long-Term Profit Growth

A Relative Strength Rating upgrade for ResMed shows improving technical performance. Will it continue?

2 months ago - Investor's Business Daily